Innomar Strategies
Michelle De La Croix is a seasoned professional in regulatory affairs with over 12 years of experience. Currently serving as a Senior Consultant at Innomar Strategies since April 2018, Michelle previously held the position of Senior Director of Regulatory Affairs at Therapeutic Products Inc. from March 2014 to May 2018. Michelle's career includes significant roles at Optuminsight, formerly CanReg, where responsibilities included Director of PV Operations and Director of the CTA Group from February 2002 to March 2014. Michelle specializes in providing strategic regulatory advice for Clinical Trials and Clinical Trial Applications across a diverse range of products and therapeutic indications.
This person is not in any teams
This person is not in any offices
Innomar Strategies
2 followers
Innomar Strategies, a part of AmerisourceBergen, is the leading patient support provider in the Canadian specialty biopharmaceutical market. We deliver end-to-end commercialization solutions to improve product access, increase supply chain efficiency and enhance patient care. Strategic consulting, patient support programs, nursing and clinical services, and specialty pharmacy and logistics are just a few of our key areas of specialization. We partner closely with manufacturers, healthcare providers, pharmacies and payers to ensure patients have consistent and reliable access to specialty medication. With our integrated approach and commitment to best-in-class care, Innomar Strategies helps navigate the patient journey to optimize health outcomes.